LONA
LeonaBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.98
−4.23%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-421.1%
Return on equity
-248.6%
Return on assets
-360.0%
Return on invested capital
0.00x
Asset turnover
-$61.9M
Cash from operations
$5.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026